SCHEMBL8870298

SCHEMBL8870298

CC(=O)N[C@H]1C[C@H](C)N(Cc2ccccc2)C1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 1/20 0.57
▸ PDK1 Q15118 1/20 0.46
▸ PDK2 Q15119 1/20 0.46
▸ PDK3 Q15120 1/20 0.46
▸ PDK4 Q16654 1/20 0.46
▸ BRD4 O60885 2/20 0.45
▸ MEN1 O00255 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ OGA O60502 1/20 0.42
▸ ALDH1A1 P00352 1/20 0.41
▸ PTGDR2 Q9Y5Y4 1/20 0.41
▸ LTA4H P09960 2/20 0.41
▸ SIGMAR1 Q99720 1/20 0.41
▸ ATM Q13315 1/20 0.40
▸ JAK2 O60674 1/20 0.40
▸ JAK1 P23458 1/20 0.40
▸ TYK2 P29597 1/20 0.40
▸ JAK3 P52333 1/20 0.40
▸ MTNR1A P48039 1/20 0.40
▸ MTNR1B P49286 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9490686 1.00 MAPT (0.57) MAPTPDK1PDK2PDK3PDK4
SCHEMBL8936180 1.00 MAPT (0.57) MAPTPDK1PDK2PDK3PDK4
SCHEMBL7374851 0.85 MAPT (0.47) MAPTPDK1PDK2PDK3PDK4
SCHEMBL16978164 0.84 BRD4 (0.47) MAPTBRD4MEN1KMT2AOGA
SCHEMBL15595187 0.84 OGA (0.46) MAPTMEN1KMT2AOGAALDH1A1
SCHEMBL18922700 0.84 OGA (0.46) MAPTMEN1KMT2AOGAALDH1A1
SCHEMBL9308794 0.82 KMT2A (0.61) MAPTPDK1PDK2PDK3PDK4
SCHEMBL8566009 0.82 KMT2A (0.61) MAPTPDK1PDK2PDK3PDK4
SCHEMBL8869835 0.82 KMT2A (0.61) MAPTPDK1PDK2PDK3PDK4
SCHEMBL16022317 0.82 KMT2A (0.61) MAPTPDK1PDK2PDK3PDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5624924-A Quinobenzothiazine antineoplastic agents ABBOTT LABORATORIES (US) 1997-04-29 — — US disclosed
US-5580872-A ADMINISTERING IN THE TREATMENT OF BACTERIAL INFECTIONS ABBOTT LABORATORIES (US) 1996-12-03 — — US disclosed
EP-0659178-A4 CHIRAL QUINOLONE INTERMEDIATES. ABBOTT LAB (US) 1996-03-27 — — EP disclosed
EP-0659178-A1 CHIRAL QUINOLONE INTERMEDIATES ABBOTT LABORATORIES (US) 1995-06-28 — — EP disclosed
WO-1994006766-A1 CHIRAL QUINOLONE INTERMEDIATES ABBOTT LABORATORIES (US) 1994-03-31 — — WO disclosed
US-5252747-A Chiral quinolone intermediates ABBOTT LABORATORIES (US) 1993-10-12 — — US disclosed
Send feedback